BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 9100048)

  • 21. Heterogeneity in gentamicin clearance between high-efficiency hemodialyzers.
    Agarwal R; Cronin RE
    Am J Kidney Dis; 1994 Jan; 23(1):47-51. PubMed ID: 8285197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers.
    Smeby LC; Widerøe TE; Balstad T; Jørstad S
    Blood Purif; 1986; 4(1-3):93-101. PubMed ID: 3730167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
    Kadiri S; Kehinde Z; Arije A; Salako BL
    Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, controlled study of the consequences of hemodialysis membrane composition on erythropoietic response.
    Richardson D; Lindley EJ; Bartlett C; Will EJ
    Am J Kidney Dis; 2003 Sep; 42(3):551-60. PubMed ID: 12955684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effects of polysulfone and polyester-polymer alloy dialyzers on glycemic control in diabetic patients undergoing hemodialysis.
    Abe M; Okada K; Maruyama T; Ikeda K; Kikuchi F; Kaizu K; Matsumoto K
    Clin Nephrol; 2009 May; 71(5):514-20. PubMed ID: 19473611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postdialysis urea rebound: determinants and influence on dialysis delivery in chronic hemodialysis patients.
    Leblanc M; Charbonneau R; Lalumière G; Cartier P; Déziel C
    Am J Kidney Dis; 1996 Feb; 27(2):253-61. PubMed ID: 8659502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of the hemodialysis adequacy conducted based on low-flux polysulfone dialyzers and high-flux helixone dialyzers].
    Sobaszek-Pitas M; Kopeć J; Krzanowski M; Sułowicz W
    Przegl Lek; 2014; 71(7):384-8. PubMed ID: 25338334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of electron-beam sterilized hemodialysis membranes and risk of thrombocytopenia.
    Kiaii M; Djurdjev O; Farah M; Levin A; Jung B; MacRae J
    JAMA; 2011 Oct; 306(15):1679-87. PubMed ID: 22009100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of a membrane dialyzer during hemodialysis on the antioxidant status and lipid peroxidation of patients with end-stage renal disease.
    Ogunro PS; Olujombo FA; Ajala MO; Oshodi TT
    Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1186-93. PubMed ID: 25394434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residual blood loss in single use dialyzers: effect of different membranes and flux.
    Kalocheretis P; Vlamis I; Belesi C; Makriniotou I; Zerbala S; Savidou E; Zorbas S; Arvanitis N; Iatrou C
    Int J Artif Organs; 2006 Mar; 29(3):286-92. PubMed ID: 16685672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane.
    Sirolli V; Ballone E; Di Stante S; Amoroso L; Bonomini M
    Int J Artif Organs; 2002 Jun; 25(6):529-37. PubMed ID: 12117292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of plasma insulin and C-peptide levels with 3 different high-flux dialyzers in diabetic patients on hemodialysis.
    Abe M; Okada K; Maruyama T; Inoshita A; Ikeda K; Uto E; Kikuchi F; Matsumoto K
    Int J Artif Organs; 2008 Oct; 31(10):898-904. PubMed ID: 19009508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Plasma Proteins on the Transport and Surface Characteristics of Polysulfone/Polyethersulfone and Asymmetric Cellulose Triacetate High Flux Dialyzers.
    Kim TR; Hadidi M; Motevalian SP; Sunohara T; Zydney AL
    Artif Organs; 2018 Nov; 42(11):1070-1077. PubMed ID: 29774568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure].
    Starzyk J; Bartelik S; Sarnecka S
    Wiad Lek; 1994 Jul; 47(13-14):523-6. PubMed ID: 7716940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rebound kinetics of beta2-microglobulin after hemodialysis.
    Leypoldt JK; Cheung AK; Deeter RB
    Kidney Int; 1999 Oct; 56(4):1571-7. PubMed ID: 10504510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized controlled open-label trial of vitamin E-bonded polysulfone dialyzer and erythropoiesis-stimulating agent response.
    Sanaka T; Mochizuki T; Kinugasa E; Kusano E; Ohwada S; Kuno T; Kojima K; Kobayashi S; Satoh M; Shimada N; Nakao K; Nakazawa R; Nishimura H; Noiri E; Shigematsu T; Tomo T; Maeda T;
    Clin J Am Soc Nephrol; 2013 Jun; 8(6):969-78. PubMed ID: 23599410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of hemodialysis membrane on serum lipid profile of maintenance hemodialysis patients].
    Tanaka H; Nishikawa O; Yukawa S; Yoshimoto M; Nishide I
    Nihon Jinzo Gakkai Shi; 1999 Jan; 41(1):1-7. PubMed ID: 10077981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a reduced inner diameter of hollow fibers in hemodialyzers.
    Ronco C; Brendolan A; Lupi A; Metry G; Levin NW
    Kidney Int; 2000 Aug; 58(2):809-17. PubMed ID: 10916106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The past, present and future of the dialyzer.
    Mineshima M
    Contrib Nephrol; 2015; 185():8-14. PubMed ID: 26023010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.